Literature DB >> 9288789

Rapid detection of specific messenger RNAs in thyroid carcinomas by reverse transcription-PCR with degenerate primers: specific expression of oncofetal fibronectin messenger RNA in papillary carcinoma.

T Takano1, F Matsuzuka, H Sumizaki, K Kuma, N Amino.   

Abstract

The search for mRNAs that are specifically expressed in cancer tissues is important for gene diagnosis and therapy. However, finding such mRNAs in human cancers is usually very difficult, both because of the limited volume of RNA obtainable from the tissues and the many technical difficulties of RNA analysis. To address these problems, the present study compared mRNA from thyroid cancer tissues with those from normal and benign tissues by reverse transcription-PCR using two degenerate primers. Amplified cDNAs were separated by electrophoresis with nondenaturing acrylamide gel, then three bands that are increased in cancer tissues were selected, reamplified by PCR, and cloned into T-vector. One of the bands was determined by sequencing analysis to be oncofetal fibronectin. The expression of oncofetal fibronectin mRNA in benign and malignant tissues was examined by Northern blot and reverse transcription-PCR using specific primers of its cDNA sequence, and its increased expression was observed only in papillary and anaplastic carcinomas. Thus, the present method rapidly detected specific mRNAs in cancer tissues, and one of these, oncofetal fibronectin mRNA, is a good target for gene diagnosis of papillary carcinoma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9288789

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Gene expression in papillary thyroid carcinoma reveals highly consistent profiles.

Authors:  Y Huang; M Prasad; W J Lemon; H Hampel; F A Wright; K Kornacker; V LiVolsi; W Frankel; R T Kloos; C Eng; N S Pellegata; A de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

2.  Analysis of splice variants of the fibronectin gene in thyroid carcinomas by reverse transcription-polymerase chain reaction: increased expression of oncofetal fibronectin mRNA in papillary carcinomas is not caused by the alternation in splicing.

Authors:  T Takano; F Matsuzuka; G Liu; A Miyauchi; T Yokozawa; K Kuma; N Amino
Journal:  J Endocrinol Invest       Date:  1999-01       Impact factor: 4.256

3.  Proteomic and postproteomic characterization of keratan sulfate-glycanated isoforms of thyroglobulin and transferrin uniquely elaborated by papillary thyroid carcinomas.

Authors:  Gaetano Magro; Daniela Perissinotto; Monica Schiappacassi; Steffen Goletz; Albrecht Otto; Eva-Christina Müller; Michele Bisceglia; Gavin Brown; Timothy Ellis; Sebastiano Grasso; Alfonso Colombatti; Roberto Perris
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

4.  Gene expression profiles in thyroid carcinomas.

Authors:  T Takano; Y Hasegawa; F Matsuzuka; A Miyauchi; H Yoshida; T Higashiyama; K Kuma; N Amino
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

5.  Oncofoetal fibronectin--a tumour-specific marker in detecting minimal residual disease in differentiated thyroid carcinoma.

Authors:  E Hesse; P B Musholt; E Potter; T Petrich; M Wehmeier; R von Wasielewski; R Lichtinghagen; T J Musholt
Journal:  Br J Cancer       Date:  2005-09-05       Impact factor: 7.640

Review 6.  The Pathogenetic Role of the HGF/c-Met System in Papillary Carcinoma of the Thyroid.

Authors:  Luigi Ruco; Stefania Scarpino
Journal:  Biomedicines       Date:  2014-10-24

7.  Restricted expression of oncofetal fibronectin mRNA in thyroid papillary and anaplastic carcinoma: an in situ hybridization study.

Authors:  T Takano; F Matsuzuka; A Miyauchi; T Yokozawa; G Liu; S Morita; K Kuma; N Amino
Journal:  Br J Cancer       Date:  1998-07       Impact factor: 7.640

8.  An Extracellular Matrix Molecule, Secreted by the Epithelial-Mesenchymal Transition is Associated With Lymph Node Metastasis of Thyroid Papillary Carcinoma.

Authors:  Hiroshi Takeyama; Yoshinobu Manome; Kouki Fujioka; Isao Tabei; Hiroko Nogi; Yasuo Toriumi; Kumiko Kato; Makiko Kamio; Yoshimi Imawari; Satoki Kinoshita; Naoshi Akiba; Ken Uchida; Toshiaki Morikawa
Journal:  Int J Endocrinol Metab       Date:  2014-01-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.